ConductScience.org, home

Paper347307

The narcotic antagonist naloxone enhances clinical pain.

Levine JD and 3 others. Nature, 1978. Cited by 205 papers, by iCite.

Cite this record

ConductScience Library. The narcotic antagonist naloxone enhances clinical pain. Papers, record 347307. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/347307

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The narcotic antagonist naloxone enhances clinical pain.
PubMed
Journal
Nature
PubMed
Year
1978
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
205
iCite
Relative citation ratio, by iCite
7.11
iCite
Revised in PubMed
2019-06-17
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Levine JDJ D
2Gordon NCN C
3Jones RTR T
4Fields HLH L

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NaloxoneMajor topic
PainMajor topic
Adolescent
Adult
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Male
Tooth, Impacted

Source PubMed

Download CSV of topics

Cited by43

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 205 citations.

PMIDTitleJournalYearIn PapersSource
41611854Machine learning models for drug-drug interaction prediction from computational discovery to clinical application.NPJ Digit Med2026https://conductscience.org/library/papers/41611854PubMed
40817381Effects of open-label placebos across populations and outcomes: an updated systematic review and meta-analysis of randomized controlled trials.Sci Rep2025https://conductscience.org/library/papers/40817381PubMed
40274927Comparing neural responses to cutaneous heat and pressure pain in healthy participants.Sci Rep2025https://conductscience.org/library/papers/40274927PubMed
39156196The Brain Salience Network at the Intersection of Pain and Substance use Disorders: Insights from Functional Neuroimaging Research.Curr Addict Rep2024https://conductscience.org/library/papers/39156196PubMed
39045468Single-neuron projectome-guided analysis reveals the neural circuit mechanism underlying endogenous opioid antinociception.Natl Sci Rev2024https://conductscience.org/library/papers/39045468PubMed
35890193Druggable Targets and Compounds with Both Antinociceptive and Antipruritic Effects.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35890193PubMed
35128295Anxiety enhances pain in a model of osteoarthritis and is associated with altered endogenous opioid function and reduced opioid analgesia.Pain Rep2021https://conductscience.org/library/papers/35128295PubMed
33567346Arbiters of endogenous opioid analgesia: role of CNS estrogenic and glutamatergic systems.Transl Res2021https://conductscience.org/library/papers/33567346PubMed
32091619Harnessing endogenous opioids for pain relief: Fantasy vs reality.J Opioid Manag2019https://conductscience.org/library/papers/32091619PubMed
32038168Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management.Front Mol Neurosci2020https://conductscience.org/library/papers/32038168PubMed
30557590Exploiting endogenous opioids: Lessons learned from endomorphin 2 in the female rat.Peptides2019https://conductscience.org/library/papers/30557590PubMed
30366152Pharmacological Modulation of Endogenous Opioid Activity to Attenuate Neuropathic Pain in Rats.J Pain2019https://conductscience.org/library/papers/30366152PubMed
29025923
Plasticity of Signaling by Spinal Estrogen Receptor α, κ-Opioid Receptor, and Metabotropic Glutamate Receptors over the Rat Reproductive Cycle Regulates Spinal Endomorphin 2 Antinociception: Relevance of Endogenous-Biased Agonism.
J Neurosci2017https://conductscience.org/library/papers/29025923PubMed
26554360Effect of a high-dose target-controlled naloxone infusion on pain and hyperalgesia in patients following groin hernia repair: study protocol for a randomized controlled trial.Trials2015https://conductscience.org/library/papers/26554360PubMed
25883069Genetics and the placebo effect: the placebome.Trends Mol Med2015https://conductscience.org/library/papers/25883069PubMed
25227929Endogenous analgesia, dependence, and latent pain sensitization.Curr Top Behav Neurosci2014https://conductscience.org/library/papers/25227929PubMed
24460691Positive allosteric modulators of the μ-opioid receptor: a novel approach for future pain medications.Br J Pharmacol2015https://conductscience.org/library/papers/24460691PubMed
23891755Neural processing of itch.Neuroscience2013https://conductscience.org/library/papers/23891755PubMed
23754417Discovery of positive allosteric modulators and silent allosteric modulators of the μ-opioid receptor.Proc Natl Acad Sci U S A2013https://conductscience.org/library/papers/23754417PubMed
23748117Endogenous opioid function mediates the association between laboratory-evoked pain sensitivity and morphine analgesic responses.Pain2013https://conductscience.org/library/papers/23748117PubMed

See all 43 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/347307

GET https://conductscience.org/api/papers/v1/347307/cited_by?page=2